Kingworld Medicines Group Ltd. ( (HK:1110) ) has issued an update.
Kingworld Medicines Group Ltd. has announced a final cash dividend of HKD 0.0317 per share for the financial year ending December 31, 2024. This decision, approved by shareholders on May 29, 2025, reflects the company’s commitment to returning value to its shareholders. The ex-dividend date is set for June 5, 2025, with the payment date scheduled for June 30, 2025. This announcement underscores the company’s stable financial performance and its strategic focus on maintaining shareholder confidence.
More about Kingworld Medicines Group Ltd.
Kingworld Medicines Group Ltd. operates in the pharmaceutical industry, focusing on the distribution and retail of health products and medicines. The company primarily serves the Hong Kong market, offering a range of products aimed at improving health and wellness.
YTD Price Performance: 1.09%
Average Trading Volume: 948,655
Technical Sentiment Signal: Buy
Current Market Cap: HK$282M
Learn more about 1110 stock on TipRanks’ Stock Analysis page.